Cargando…
Reimagining diversity in multiple myeloma clinical trials
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790672/ https://www.ncbi.nlm.nih.gov/pubmed/35391496 http://dx.doi.org/10.1002/hon.2997 |
_version_ | 1784859231822807040 |
---|---|
author | Habr, Dany Corsaro, Massimo |
author_facet | Habr, Dany Corsaro, Massimo |
author_sort | Habr, Dany |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9790672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97906722022-12-28 Reimagining diversity in multiple myeloma clinical trials Habr, Dany Corsaro, Massimo Hematol Oncol Commentary John Wiley and Sons Inc. 2022-04-13 2022-10 /pmc/articles/PMC9790672/ /pubmed/35391496 http://dx.doi.org/10.1002/hon.2997 Text en © 2022 Pfizer Inc. Hematological Oncology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Commentary Habr, Dany Corsaro, Massimo Reimagining diversity in multiple myeloma clinical trials |
title | Reimagining diversity in multiple myeloma clinical trials |
title_full | Reimagining diversity in multiple myeloma clinical trials |
title_fullStr | Reimagining diversity in multiple myeloma clinical trials |
title_full_unstemmed | Reimagining diversity in multiple myeloma clinical trials |
title_short | Reimagining diversity in multiple myeloma clinical trials |
title_sort | reimagining diversity in multiple myeloma clinical trials |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790672/ https://www.ncbi.nlm.nih.gov/pubmed/35391496 http://dx.doi.org/10.1002/hon.2997 |
work_keys_str_mv | AT habrdany reimaginingdiversityinmultiplemyelomaclinicaltrials AT corsaromassimo reimaginingdiversityinmultiplemyelomaclinicaltrials |